Results 171 to 180 of about 60,582 (221)
Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin [PDF]
Antonio Girolami +4 more
openalex +1 more source
Metabolic syndrome is associated with adverse stroke outcomes. KLK1 acts as a mediating factor linking metabolic syndrome and stroke prognosis. KLK1 could be a therapeutic target for stroke patients with metabolic comorbidities. ABSTRACT Metabolic syndrome (MetS) poses a significant risk to the cerebrovascular system, impacting the prognosis of stroke ...
Hang Ruan +7 more
wiley +1 more source
Early application of modified A-OK protocol for amniotic fluid embolism: Case series report. [PDF]
He S, Tao B.
europepmc +1 more source
Abstract This report describes the diagnosis, treatment and long‐term follow‐up of a dog with hepatic arteriovenous malformation and extensive thrombus of the splanchnic vessels. A 1‐year‐old, male, neutered golden retriever presented with haematochezia and ascites.
Yuqing Sun +2 more
wiley +1 more source
Efficacy and safety of naphlimostat mesylate versus sodium citrate in CRRT for EICU patients with coagulation dysfunction: A STROBE-compliant observational study. [PDF]
Song B, Liu C, Fu K.
europepmc +1 more source
Abstract A 13‐year‐old dog with no history of spontaneous bleeding was presented for evaluation of multiple diffusely distributed cutaneous mast cell tumours. No obvious metastasis was found, and chemotherapy with vinblastine/lomustine was initiated. After the second dose of lomustine was administered, the dog experienced epistaxis for 2–3 minutes per ...
Andrew Schlueter, Rance Sellon
wiley +1 more source
Old Scars, New Bleeds: Revisiting Coagulopathy in Quiescent Crohn's Disease. [PDF]
Patel S +4 more
europepmc +1 more source
Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non‐valvular atrial fibrillation [PDF]
Daiki Shimomura +14 more
openalex +1 more source
Feasibility and Safety of Cytosorb Application in Patients With Acute Liver Failure
ABSTRACT Background and Aims Acute liver failure (ALF) is a rare, life‐threatening condition with high mortality and limited therapeutic options beyond liver transplantation. Cytosorb adsorber can be easily applied to continuous renal replacement therapy (CRRT) and potentially support liver function by removing bilirubin and cytokines.
Haselwanter Patrick +10 more
wiley +1 more source

